AERI
Aerie Pharmaceuticals
AERI
AERI
Delisted
AERI was delisted on the 18th of November, 2022.
104 hedge funds and large institutions have $489M invested in Aerie Pharmaceuticals in 2016 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 51 increasing their positions, 25 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
2% more funds holding
Funds holding: 102 → 104 (+2)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
104
Holding in Top 10
2
Calls
$4.92M
Puts
$647K
Top Buyers
| 1 | +$6.83M | |
| 2 | +$3.34M | |
| 3 | +$3.02M | |
| 4 |
SCM
Suffolk Capital Management
New York
|
+$2.09M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.77M |
Top Sellers
| 1 | -$2.38M | |
| 2 | -$1.97M | |
| 3 | -$1.97M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$1.38M |
| 5 |
CCI
Columbus Circle Investors
|
-$1.15M |